Princeton Global Asset Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
DRP
YIH
PP
APW
Princeton Global Asset Management's ABCL Position: Q2 2026 in Review
Princeton Global Asset Management held its AbCellera Biologics (ABCL) position steady in Q2 2026 at 1,000 shares worth $7.85K. The position accounts for ﹤0.01% of the portfolio, ranked #614.
Princeton Global Asset Management first reported a position in ABCL in Q3 2025 and has held it in 4 quarters since. 6 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.
- Princeton Global Asset Management held 1,000 shares of AbCellera Biologics worth $7.85K as of Q2 2026.
- Princeton Global Asset Management left its AbCellera Biologics share count unchanged in Q2 2026.
- AbCellera Biologics made up ﹤0.01% of Princeton Global Asset Management's portfolio in Q2 2026, its #614 holding.
- Princeton Global Asset Management first reported a position in AbCellera Biologics in Q3 2025 and has held it in 4 quarters since.
- 6 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.
Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.